Form 4 for ONC BeOne Medicines Ltd.
Accepted 2025-06-25 00:00:00 ET · period of report 2025-06-23 · accession 0001651308-25-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-06-25 | 2025-06-23 | ONC | OYLER JOHN | CEO, Dir | S - Sale | $261.61 | -3,174 | 0 | -100% | -$830.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American Depositary Shares | 2025-06-23 | S | D | 3,074 | $261.57 | 100 | D | — | — | (F6) Each American Depositary Share represents 13 Ordinary Shares |
| 2 | Common | American Depositary Shares | 2025-06-23 | S | D | 100 | $262.90 | 0 | D | — | — | (F6) Each American Depositary Share represents 13 Ordinary Shares |